When Jess Williams had Sarah Shotland as a writing teacher in a Chatham University course, she didn’t know they’d later band together to address stigma around medication for opioid use disorder.
While opioid overdoses are on a slight decline nationwide, tens of thousands still face judgment from using drugs or having used them — something a local group called PGH MOUD, which stands for Pittsburgh Medication Opioid Use Disorder — hopes to change.
An estimated 1,025,000 people with a diagnosed opioid use disorder received medication for it in 2023, according to a survey on drug use and health conducted by the Substance Abuse and Mental Health Services Administration, an agency under the U.S. Department of Health and Human Services.
But nearly 9 million people 12 and over reported misusing opioids in 2023, meaning only a fraction who need help are prescribed medication for it.
Medication for opioid use disorder (MOUD), such as methadone and buprenorphine, works by activating the brain’s opioid receptors to prevent cravings and withdrawal, which can be dangerous.
“These medications are important in the simple sense that they help keep people alive and safe,” said Paul Joudrey, assistant professor of medicine at Pitt’s School of Medicine and a physician who works with people with opioid use disorders. “These are long-acting opioids that are safe if taken as prescribed, and they allow people to stop street use.”
Read More
If people continue to use drugs from the illicit supply, they are at great risk of overdose and death due to fentanyl, said Joudrey.
Myths hindering treatment discussions
MOUD is recognized as a first-line treatment for opioid addiction by the American Medical Association, the National Institute on Drug Abuse and the Food and Drug Administration, among others. A body of research shows it reduces repeat overdoses and increases retention in treatment programs. One 2022 study found that receipt of an MOUD prescription decreased the risk of repeat overdose by two-thirds.
But myths remain that the treatment enables drug users’ habits, leading many to keep quiet about their experience with the treatment.
This is something Williams knows well. The 40-year-old social worker and therapist from Bloomfield wanted to increase the number of speakers at the annual Pittsburgh Recovery Walk who could share their stories about being on MOUD. Williams, in recovery herself from a variety of substances, had been volunteering with the walk for years.
She struggled to find people who wanted to be that open at a public event like the recovery walk, so she applied for — and ultimately was awarded — an $8,000 grant from the organization Shatterproof to help train a handful of people to be vulnerable in telling their stories.
She soon learned that was far from enough.
“I am very lucky that people were so wise and experienced and were willing to caution me that I was probably being simplistic about the deep-seated issue of stigma in recovery and with MOUD,” she said.
Much of that boils down to being able to access dedicated spaces with people who share similar experiences. Many in recovery from substances other than opioids (like alcohol) have access to these safe spaces (like Alcoholics Anonymous) she said.
“For folks on Suboxone (buprenorphine) and methadone, there is a shortage of those spaces,” said Williams. “It’s unfair to send people out into the public wilderness to tell their story without that scaffolding and structural support of existing safe spaces.”
Creating ways to safely share stories
So Williams worked to create that. With the launch of PGH MOUD in 2022, the group of 10 or so individuals started the Medication-Assisted Recovery Anonymous (MARA) online meetings, which recurred with a core group for a year.
They also published a small “zine” that explained what MOUD was, where safe spaces were located in Pittsburgh, and how to respond to common myths and misconceptions about using the medication.
The group printed and distributed 1,500 copies of the zine and provided the materials for free online for others to do the same.
“We know some have been printed and distributed in unlikely places, which is cool,” she said. “We wanted the model to be, whoever liked it could do whatever they wanted with it.”
Battling the misconceptions
One of the misconceptions PGH MOUD aims to address is that being on MOUD is simply replacing one opioid for another, and that it doesn’t count for these people to be in recovery.
Many recovery houses in the area do not allow people who have MOUD prescriptions to stay there, out of fear of misuse or relapse.
While methadone and buprenorphine are indeed opioids, the difference between them and other opioids like heroin, fentanyl or Oxycontin is the difference between being dependent and being addicted, said Joudrey.
“You could be drinking coffee every day, and if you stop one day, you’ll get a headache — that’s being dependent,” he said. “It would be weird to say you’re addicted to coffee.”
That’s because addiction negatively affects your ability to live in society and to maintain relationships, he explained. Even though buprenorphine and methadone are opioids, they do the opposite of that — by allowing people to stabilize and to make improvements in their lives.
Hearing stories about people who have taken, and are still taking, MOUD, helps others understand that.
“Recovery is not about subtraction,” said Shotland, an assistant professor of English and program director of the creative writing program at Carlow and a person in recovery herself. “It is about addition. It is about adding things to your life that make it a life worth living.”
Shotland said she took MOUD for six years to help her stabilize after a decade of opioid use following the traumatic death of her boyfriend when she was 15.
“It wasn’t like I was taking that medication and that was all I was doing for my recovery,” said Shotland. “It was a stabilizing medicine so that I could reclaim the life I had, which was interrupted by drug use.”
Shotland found PGH MOUD by way of Williams, who enrolled in Shotland’s writing course at Chatham for women in recovery in 2021. Shotland’s professional practice, in addition to teaching at Chatham, involves facilitating writing workshops to help people tell their own stories. She founded Words Without Walls, a writing workshop for people in jail and prison, and she is also the author of a novel and a memoir.
Stereotypes emerge from believing that only one story exists, said Shotland. The way to shatter those stereotypes is with more storytelling.
The zine that PGH MOUD made includes free spaces for people to write about their own experiences. The prompts ask, what are your ideas for “coming out” as a person in recovery? What myths about MOUD have you heard or have you told yourself?
“As a writer, I’m obsessed with how people tell the story of themselves to themselves,” said Shotland. “One of the main challenges of reducing stigma is that internalized story of self. The group did some good work shifting and interrupting narratives that we as group members were telling ourselves about our own stories.”
‘It needs to keep going’
PGH MOUD is currently on hold as they work to get more grant money to support the project, said Williams.
They want to create a more local charter for the MARA meetings, which gained national and international reach but rarely represented local residents.
Williams also has ideas for a part two of the zine, addressing different aspects of MOUD, she said.
It’s easier now than when she started the group to find people who are willing to talk, and that’s a testament to progress already made, said Williams.
“I’ve been really excited by how much enthusiasm there’s been for it,” she said. “I think it needs to keep going, because there’s a desire and a need.”
Nationally, MOUD is gaining credibility as a solid treatment for opioid use disorder, whereas decades before, it was seen as taboo or experimental.
In February, the U.S. Department of Health and Human Services ruled that buprenorphine could be prescribed to people with opioid use disorder via telehealth to increase access to the medication and reduce barriers for many with socioeconomic challenges, such as a lack of transportation or need for childcare. It also increased access to methadone treatment via opioid treatment providers, or licensed centers that prescribe the drug. The American Medical Association lauded the move.
Joudrey said that as a clinician, it’s been exciting to see groups like PGH MOUD form and people in recovery who work in the medical field being more open about their experiences as a result. Clinicians can do better about “getting out of the way” of these types of organizations, he said, and simply supporting their efforts.
“Groups like this are a great sign that things are getting a little better,” he said.
For Shotland, it means people have “a little less anxiety in starting to tell their story,” she said, “And starting to tell your story is a really big step.”






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.